Abstract: This invention relates to Lactobacillus, skim milk, Lactobacillus Growth Factor (LGF) and Lactobacillus compositions and methods of employing the compositions for preventing urogenital infections. More particularly, this invention relates to the ability of strains of hydrophobic or hydrophilic Lactobacillus to adhere to biomaterials, and intestinal, vaginal and uroepithelial cells, to resist the action of certain antimicrobial agents and to dominate the urogenital flora.
Abstract: This invention relates to a process for forming an amide or an ester from a reaction between an amine or an alcohol, respectively and an acylating derivative of a carboxylic acid, in the presence of an effective amount of a compound having the formula: ##STR1## and N-oxides thereof and salts thereof.
Abstract: The present invention relates to promoter elements from human type I transglutaminase (TGase I) genes for controlled gene expression of both human TGase I and heterologous proteins. These promoter elements permit tissue-specific expression of genes, e.g. for use in human gene therapy and for testing pharmaceutical agents with artificial skin. Additionally, the subject promoter elements can provide differential regulation under physiological conditions or in the presence of exogenously added factors including calcium and retinoic acid.
Type:
Grant
Filed:
March 21, 1994
Date of Patent:
July 1, 1997
Assignee:
Research Corporation Technologies, Inc.
Inventors:
Renata Regina Polakowska, Lowell Alan Goldsmith
Abstract: The present invention relates to novel compounds useful for the treatment and prophylaxis of degenerative bone disorders and to the preparation thereof. These compounds are particularly characterized by two active moieties, the first of which possesses "bone-seeking" affinity and the second which is an inhibition of the enzyme carbonic anhydrase and/or an inhibitor of bone resorption. The novel compounds of this invention can be administered as pharmaceutically acceptable compositions and in convenient dosage unit form in a method for the treatment and prophylaxis of degenerative bone disorders.
Type:
Grant
Filed:
July 1, 1994
Date of Patent:
June 24, 1997
Assignee:
Research Corporation Technologies, Inc.
Inventors:
William M. Pierce, Jr., Leonard C. Waite
Abstract: The present invention relates to bis-imidazolyl compounds of the formula: ##STR1## and polymers having the above-identified bis-imidazolyl compounds as a polymerizable unit. The present invention further relates to a method for scavenging trace quantities of metal ions from various effluents sources using the polymers of the instant invention. The instant invention also is directed to the use of the above-identified polymers as corrosion inhibiting agents and as a film for use in gel electrophoresis.
Type:
Grant
Filed:
June 6, 1995
Date of Patent:
June 10, 1997
Assignee:
Research Corporation Technologies, Inc.
Inventors:
J. Thomas Ippoliti, Gary A. Mabbott, Jeremy Hans, Michelle Stohlmeyer
Abstract: Methods of using chiral catalysts for enantioselectively epoxidizing a prochiral olefin and for enantioselectively oxidizing a prochiral sulfide are disclosed. In accordance with one aspect of the invention, the catalyst used is a salen derivative which has the following general structure: ##STR1## In accordance with another aspect of the present invention is a method of producing an epoxychroman using a chiral catalyst. In accordance with this method, a chromene derivative, an oxygen atom source, and a chiral catalyst are reacted under such conditions and for such time as is needed to epoxidize said chromene derivative. In accordance with yet another aspect of this invention is a method of enantioselectively epoxidizing a cis-cinnamate derivative to make taxol or an analog thereof. In accordance with another aspect a method of disproportionation of hydrogen peroxide using the catalysts of the present invention is disclosed.
Abstract: The compounds of the present invention are adaptable as blocking or protecting groups for an amine composition useful in peptide synthesis. The present invention is directed to a method of protecting an amino group of an organic molecule during a reaction which modifies a portion of the molecule other than the protected amino group.
Abstract: The present invention is directed to derivatives of aroyl-2-quinoline-carboxaldehyde and their use in detection and quantification of minute amounts of primary amines.
Type:
Grant
Filed:
October 28, 1993
Date of Patent:
May 20, 1997
Assignee:
Research Corporation Technologies, Inc.
Inventors:
Milos V. Novotny, Donald Wiesler, Jinping Liu, You-Zung Hsieh
Abstract: Derivatives of 7-alkylidene cephalosporanic acid sulfone and the pharmaceutically active salts thereof are found to be potent inhibitors of .beta.-lactamase enzymes.
Abstract: The present invention is directed to use of Aedes aegypti densonucleosis virus (Aedes DNV or AeDNV) as a heterologous gene expression system. The invention described herein provides promoters from the Aedes aegypti genome such as the p.05, p7 and p61 promoters to generate expression vectors with cloning sites for insertion of heterologous genes. The invention further provides expression vectors comprising an AeDNV promoter operably linked to a heterologous gene and insect host cells comprising the vectors of the invention. Methods of producing recombinant proteins utilizing the vectors of the invention are also provided. The present invention further provides a kit containing the vectors of the invention for production of a recombinant protein.
Type:
Grant
Filed:
November 4, 1994
Date of Patent:
May 6, 1997
Assignee:
Research Corporation Technologies, Inc.
Inventors:
Boris N. Afanasiev, Jonathan O. Carlson, Barry Beaty, David R. Higgins, Kelly J. Thibault
Abstract: The present invention relates to various methods, such as an above-ground method and an in-ground method, of using a palladized iron bimetallic system for the dechlorination of chlorinated organic compounds from various effluents or contaminated soil containing the same. The use of palladized iron bimetallic system results in the dechlorination of the chlorinated organic compound into environmentally safe reaction products.
Type:
Grant
Filed:
March 25, 1996
Date of Patent:
April 1, 1997
Assignee:
Research Corporation Technologies, Inc.
Inventors:
Quintus Fernando, Rosy Muftikian, Nic Korte
Abstract: The present invention relates to various methods, such as an above-ground method and an in-ground method, of using a palladized iron bimetallic system for the dechlorination of chlorinated organic compounds from effluents containing the same. The use of palladized iron bimetallic system results in the dechlorination of the chlorinated organic compound into environmentally safe reaction products. The present invention also provides kits, devices, and other instruments that use the above-mentioned palladized iron bimetallic system for the dechlorination of chlorinated organic compounds.
Type:
Grant
Filed:
December 23, 1994
Date of Patent:
March 18, 1997
Assignee:
Research Corporation Technologies, Inc.
Inventors:
Quintus Fernando, Rosy Muftikian, Nic Korte
Abstract: Group II-VI compound semiconductor light emitting devices which include at least one II-VI quantum well region of a well layer disposed between first and second barrier layers is disclosed. The quantum well region is sandwiched between first and second cladding layers of a II-VI semiconductor material. The first cladding layer is formed on and lattice matched to the first barrier layer and to a substrate of a III-V compound semiconductor material. The second cladding layer is lattice matched to the second barrier layer. The quantum well layer comprises a II-VI compound semiconductor material having the formula A.sub.x B.sub.(1-x) C wherein A and B are two different elements from Group II and C is at least one element from Group VI. When the second cladding layer has a p-type conductivity, a graded bandgap ohmic contact according to the present invention can be utilized.
Type:
Grant
Filed:
June 7, 1995
Date of Patent:
March 11, 1997
Assignee:
Research Corporation Technologies, Inc.
Inventors:
Yongping Fan, Jung Han, Arto V. Nurmikko, Robert L. Gunshor, Li He
Abstract: A method to inhibit microbial growth is provided comprising topically administering to a mammal afflicted with a pathology associated with microbial growth, such as a dermatological condition, an effective amount of a linear (C.sub.12 -C.sub.22) 3-alken-2-one or 3,.omega.-alkadien-2-one.
Abstract: The present invention relates to bis-imidazolyl compounds of the formula: ##STR1## and polymers having the above-identified bis-imidazolyl compounds as a polymerizable unit. The present invention further relates to a method for scavenging trace quantities of metal ions from various effluents sources using the polymers of the instant invention. The instant invention also is directed to the use of the above-identified polymers as corrosion inhibiting agents and as a film for use in gel electrophoresis.
Type:
Grant
Filed:
June 6, 1995
Date of Patent:
February 25, 1997
Assignee:
Research Corporation Technologies, Inc.
Inventors:
J. Thomas Ippoliti, Gary A. Mabbott, Jeremy Hans, Michelle Stohlmeyer
Abstract: A method to inhibit microbial growth is provided comprising topically administering to a mammal afflicted with a pathology associated with microbial growth, such as a dermatological condition, an effective amount of a linear (C.sub.12 -C.sub.22) 3-alken-2-one or 3,.omega.-alkadien-2-one.
Abstract: A pink-flowered soybean plant which possesses large seeds and high protein seed content, without a concomitant decrease in yield. The pink-flowered soybean plant is easily distinguished from wild-type and domesticated cultivars by virtue of its unique flower color and appearance. The two commercially significant traits, large seed size and high protein seed content, cosegregate with the pink flower trait. Seed size and protein content of soybean cultivars are therefore efficiently and quickly increased by crossing with the pink-flowered plant, then selecting for pink-flowered progeny. Prior difficulties in tracking and monitoring increases in seed protein content are eliminated.
Abstract: This invention provides a DNA sequence coding for a mammalian granulocyte macrophage colony stimulating factor (GM-CSF), a method of obtaining same, vectors and hosts harboring same. The sequence is useful as a probe for identifying related sequences, selecting GM-CSF encoding mRNA from a mixture of mRNAs containing same, and a source of GM-CSF DNA for expression in an appropriate expression vector. The GM-CSF protein encoded by the sequence is useful for stimulating the production of granulocytes and macrophages from their respective progenitor cells.
Type:
Grant
Filed:
December 9, 1988
Date of Patent:
February 11, 1997
Assignee:
Research Corporation Technologies, Inc.
Inventors:
Ashley R. Dunn, Nicholas M. Gough, Donald Metcalf
Abstract: A protective monolayer is formed on e.g. silica gel and glass surfaces comprising a monolayer of silicon and oxygen atoms which is substituted with first and second hydrocarbyl substituents.